SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Astrazeneca Pharma India informs about board meeting

19 May 2021 Evaluate
Astrazeneca Pharma India has informed that a meeting of the Board of Directors of AstraZeneca Pharma India will be held on Tuesday, May 25, 2021, to consider and approve the Audited Financial Results of the Company for the quarter and year ended March 31, 2021. The Company further informed that the ‘Trading Window’ remains closed for all Designated Persons, from March 16, 2021 to May 27, 2021 in terms of AstraZeneca Pharma India - Code of Conduct for Prevention of Insider Trading framed under Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015.

The above information is a part of company’s filings submitted to BSE.

Astrazeneca Pharma Share Price

8500.20 -3.10 (-0.04%)
24-Jun-2026 11:09 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1867.00
Dr. Reddys Labs. 1335.65
Cipla 1430.50
Zydus Lifesciences 1109.85
Lupin 2370.15
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: